Bad cholesterol slashed 62% by single dose of gene-editing drug in small trial
The interim Phase I trial data was only from 35 people, but results look good so far.
What happened?
The interim Phase I trial data was only from 35 people, but results look good so far.
Story details
The interim Phase I trial data was only from 35 people, but results look good so far.
Why it matters
This story helps build a stronger internal English tech archive around Productivity, giving search visitors more reasons to keep browsing the site instead of bouncing after a single headline.